Abstract
Small-cell lung cancer (SCLC) accounts for 20-25% of all new cases of primary lung cancer. Unlike the other major histological subtypes of lung cancer (collectively referred to as non-SCLC), SCLC is highly sensitive to both chemotherapy and radiation therapy. With combination chemotherapy a clinical response will be observed in up to 95% of all patients, and complete disappearance of all known tumor is seen in 40-50% of patients (Morstyn et al., 1984). However, in spite of the early dramatic responses observed in most patients, the vast majority will relapse with SCLC, and fewer than 10% of all patients will achieve long-term disease-free survival. The median survival for all patients is 10-11 months. Thus, there is a need to develop alternative approaches to the treatment of this tumor type.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Carney, D. N., Bunn P. A., Gazdar, A. F., Pagan, J. A., and Minna, J. D., 1981a, Selective growth in serum-free hormone supplemented medium of tumor cells obtained by biopsy from patients with small cell carcinoma of the lung, Proc. Natl. Acad. Sci. U.S.A. 78:3185–3189.
Carney, D. N., Gazdar, A. F., Bunn, P. A., and Guccion, J. G., 1981b, Demonstration of the stem cell nature of clonogenic cells in lung cancer specimens, Stem Cells 1:149–164.
Carney, D. N., Oie, H., Moody, T. W., Gazdar, A. F., Cuttitta, F., and Minna, J. D., 1983, Bombesin stimulation of small cell lung cancer growth, Clin. Res. 31:404.
Carney, D. N., Brower, M., Bertness, V., and Oie, H. K., 1984, The selective growth of human small cell lung cancer cell lines and clinical specimens in serum-free medium, in: Methods in Molecular and Cell Biology (G. Sato and D. Barnes, eds.), Alan R. Liss, New York, pp. 247–262.
Carney, D. N., Gazdar, A. G., Bepler, G., Guccion, J., Moody, T. W., Marangos, P. J., Zweig, M. H., and Minna, J. D., 1985, Establishment and identification of small cell lung cancer cell lines having classic and variant features, Cancer Res. 45:2913–2923.
Cuttitta, F., Carney, D. N., Mulshine, J., Moody, T. W., Fedorko, J., Fischler, A., and Minna, J., 1985, Bombesin-like peptides can function as autocrine growth factors in human small cell lung cancer, Nature 316:823–826.
Gazdar, A. F., Carney, D. N., Russel, E. K., Simms, H. L., Baylin, S. B., Bunn, P. A., Guccion, J. G., and Minna, J. D., 1980, Small cell carcinoma of the lung: Establishment of continuous clonable cell lines having APUD properties, Cancer Res. 40:3502–3507.
Gazdar, A. F., Carney, D. N., Nau, M., and Minna, J. D., 1985, Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological and growth properties, Cancer Res. 45:2924–2930.
Howlett, T. A., Price, J., Hale, A. C., Donlack, I., Rees, L. H., Wass, J. A. H., and Besser, G. M., 1985, Pituitary ACTH dependent Cushing’s syndrome due to ectopic production of a bombesin-like peptide by a medullary carcinoma of the thyroid, Clin. Endocrinol. 22:91–101.
Ihde, D. C., Makuch, R. W., Carney, D. N., Bunn, P. A., Cohen, M. H., Matthews, M. J., and Minna, J. D., 1981, Prognostic implications of stage of disease and sites of metastases in patients with small cell carcinoma of the lung treated with intensive chemotherapy, Am. Rev. Respir. Dis. 123:500–507.
Jensen, R. T., Jones, S. W., Folkers, K., and Gardner, J. D., 1984, A synthetic peptide that is a bombesin receptor antagonist, Nature 309:61–63.
Little, C. D., Nau, M. M., Carney, D. N., Gazdar, A. F., and Minna, J. D., 1983, Amplification and expression of the C-myc oncogene in human lung cancer cell lines, Nature 306:194–196.
McDonald, T. G., Ghatei, M. A., Bloom, S. R., Adrian, T. E., Mochizuk, T., Yanaihara, C., and Yanihara, N., 1983, Dose response comparisons of canine plasma gastroenteropancreatic hormone response to bombesin and the porcine gastrin releasing peptide, Regul. Peptides 5:125–137.
Moody, T. W., Pert, C. B., Gazdar, A. F., Carney, D. N., and Minna, J. D., 1981, High levels of intracellular bombesin characterize human small cell lung cancer, Science 214:1246–1248.
Moody, T. W., Russell, E. K., O’Donohoe, T. L., Linden, C. D., and Gazdar, A. F., 1983a, Bombesin-like peptides in small cell lung cancer; biochemical characterization and secretion from a cell line, Life Sci. 32:487–493.
Moody, T. W., Bertness, V., and Carney, D. N., 1983b, Bombesin-like peptides and receptors in human tumours, Peptides 4:683–686.
Moody, T. W., Carney, D. N., Cuttitta, F., Quattrocchi, K., and Minna, J. D., 1985, High affinity receptors for bombesin/GRP-like peptides on human small cell lung cancer, Life Sci. 37: 105–113.
Morstyn, G., Ihde, D. C., Lichter, A. S., Bunn, P. A., Carney, D. N., Glatstein, E., and Minna, J. D., 1984, Small cell lung cancer 1973-1983: Early progress and recent obstacles, Int. J. Radiát. Oncol. 10:515–539.
Pandol, S. J., Jensen, R. T., and Gardner, J. D., 1982, Mechanism of [Tyr4bombesin-induced desen-sitization in dispersed acini from guinea pig pancreas, J. Biol. Chem. 20:12024–12029.
Radice, P. A., Matthews, M. J., Ihde, D. C., Gazdar, A. F., Carney, D. N., Bunn, P. A., Cohen, M. H., Fossieck, B. E., Makuch, R. W., and Minna, J. D., 1982, The clinical behaviour of mixed small cell/large cell bronchogenic carcinoma compared to pure small cell subtypes, Cancer 50:2894–2902.
Rozengurt, E., and Sinnett-Smith, J., 1983, Bombesin stimulation of DNA synthesis and cell division in cultures of Swiss 3T3 cells, Proc. Natl. Acad. Sci. U.S.A. 80:2936–2940.
Weber, S., Zuckerman, J. E., Bostwick, D. G., Bensch, K. G., Sikic, B. I., and Raffin, T. A., 1985, Gastrin releasing peptide is a selective mitogen for small cell lung carcinoma in vitro, J. Clin. Invest. 75:306–309.
Westendorf, J. M., and Schonbrunn, A., 1983, Characterization of bombesin receptors in a rat pituitary cell line, J. Biol. Chem. 258:7527–7535.
Willey, J., Lechner, J. F., and Harris, C. C., 1984, Bombesin and the C-terminal tetradecapeptide of gastrin-releasing peptide are growth factors for normal human bronchial epithelial cells, Exp. Cell Res. 153:245–248.
Yamaguchi, K., Abe, K., Kameya, T., Actachi, I., Taguchi, S., Otsubo, K., and Yancuhara, N., 1983, Production and molecular size heterogeneity of immunoreactive gastrin releasing peptide in fetal and adult lungs and primary lung tumours, Cancer Res. 43:3932–3939.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Plenum Press, New York
About this chapter
Cite this chapter
Carney, D.N., Moody, T.W., Cuttitta, F. (1986). Bombesin/Gastrin-Releasing Peptide Stimulation of Small-Cell Lung Cancer Clonal Growth. In: Moody, T.W. (eds) Neural and Endocrine Peptides and Receptors. GWUMC Department of Biochemistry Annual Spring Symposia. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5152-8_29
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5152-8_29
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5154-2
Online ISBN: 978-1-4684-5152-8
eBook Packages: Springer Book Archive